Immunogenicity and safety of a novel formal in-inactivated and alum-adjuvanted candidate subunit vaccine for mumps

被引:9
|
作者
Liang, Yan [1 ]
Ma, Shaohui [1 ]
Yang, Zijiang [1 ]
Liu, Longding [1 ]
Wang, Lichun [1 ]
Wang, Jingjing [1 ]
Jiang, Li [1 ]
Shi, Changjun [1 ]
Dong, Chenghong [1 ]
Li, Qihan [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Med Biol Inst, Kunming 650118, Peoples R China
关键词
mumps vaccine; purified antigen; immunity; safety;
D O I
10.1016/j.vaccine.2008.05.060
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
While an attenuated vaccine against mumps has played a role in controlling the epidemic of this disease worldwide, some problems with efficacy and safety of the vaccine are still present. In the work described here, a novel mumps vaccine with good immunity and safety was developed by selecting an antigen component of the mumps virus. The results suggest that this purified antigen vaccine is immunogenic in animals and is capable of inducing a specific neutralizing antibody response against viral HN, but not against other viral proteins. The clinical and pathological observations after challenge of vaccinated rhesus monkeys indicated further that the immune response induced by this vaccine provided complete protection from wild-type virus infection. Furthermore, the immunological analysis and clinical observation of experimental monkeys that were immunized with the vaccine, followed by infection with wild-type virus, suggest that no abnormal changes in expression of inflammatory cytokines and no clinical allergic reaction were found at I month after challenge. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4276 / 4283
页数:8
相关论文
共 50 条
  • [21] An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines
    Cao, Han
    Yang, Shengran
    Wang, Yunfei
    Luan, Ning
    Yin, Xingxiao
    Lin, Kangyang
    Liu, Cunbao
    VACCINES, 2021, 9 (11)
  • [22] Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
    Giezeman, K. M.
    Nauta, J.
    de Bruijn, I. A.
    Palache, A. M.
    VACCINE, 2009, 27 (18) : 2414 - 2417
  • [23] A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine
    Tzeng, Tsai-Teng
    Chai, Kit Man
    Chen, I-Hua
    Chang, Ray-Yuan
    Chiang, Jen-Ron
    Liu, Shih-Jen
    EMERGING MICROBES & INFECTIONS, 2023, 12 (02)
  • [24] Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
    Chlibek, Roman
    Bayas, Jose M.
    Collins, Harry
    Rodriguez de la Pinta, Maria Luisa
    Ledent, Edouard
    Mols, Johann F.
    Heineman, Thomas C.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (12): : 1953 - 1961
  • [25] A safety and immunogenicity study of a novel subunit plague vaccine in cynomolgus macaques
    Liu, Li
    Wei, Dong
    Qu, Zhe
    Sun, Li
    Miao, Yufa
    Yang, Yanwei
    Lu, Jinbiao
    Du, Weixin
    Wang, Bingxiang
    Li, Bo
    JOURNAL OF APPLIED TOXICOLOGY, 2018, 38 (03) : 408 - 417
  • [26] Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
    Ye, Huayue
    Jia, Siyue
    Zhang, Yuhui
    Li, Jingxin
    Zhu, Fengcai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (11) : 2719 - 2726
  • [27] Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
    Schwarz, Tino F.
    Aggarwal, Naresh
    Moeckesch, Beate
    Schenkenberger, Isabelle
    Claeys, Carine
    Douha, Martine
    Godeaux, Olivier
    Grupping, Katrijn
    Heineman, Thomas C.
    Fauqued, Marta Lopez
    Oostvogels, Lidia
    Van den Steen, Peter
    Lal, Himal
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11): : 1352 - 1361
  • [28] Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (HSN1) vaccine in infants and children
    Nolan, Terry
    Richmond, Peter C.
    Formica, Neil T.
    Hoeschler, Katja
    Skeljo, Maryanne V.
    Stoney, Tanya
    McVernon, Jodie
    Hartel, Gunter
    Sawlwin, Daphne C.
    Bennet, Jillian
    Ryan, David
    Basser, Russell L.
    Zambon, Maria C.
    VACCINE, 2008, 26 (50) : 6383 - 6391
  • [29] Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children
    Langley, Joanne M.
    Carmona Martinez, Alfonso
    Chatterjee, Archana
    Halperin, Scott A.
    McNeil, Shelly
    Reisinger, Keith S.
    Aggarwal, Naresh
    Huang, Li-Min
    Peng, Ching-Tien
    Garcia-Sicilia, Jose
    Salamanca de la Cueva, Ignacio
    Cabanas, Fernando
    Trevino-Garza, Consuelo
    Angel Rodriguez-Weber, Miguel
    de la O, Manuel
    Chandrasekaran, Vijayalakshmi
    Dewe, Walthere
    Liu, Aixue
    Innis, Bruce L.
    Jain, Varsha K.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (04): : 544 - 553
  • [30] Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial
    Wang, Yanxia
    Zhang, Yuhui
    Wu, Haofei
    Huang, Lili
    Yu, Hailong
    Xie, Zhiqiang
    Zhang, Huiping
    Zhang, Wei
    Chen, Xiaofen
    Zhang, Huan
    Zhang, Hongdong
    Jia, Chunyu
    Xia, Shengli
    Wang, Shuai
    VACCINE, 2021, 39 (29) : 3871 - 3878